Waning antibody response and cellular immunity 6 months after third dose SARS-Cov-2 mRNA BNT162b2 vaccine in kidney transplant recipients
Dominique Bertrand, Veronique Lemée, Charlotte Laurent, Mathilde Lemoine, Mélanie Hanoy, Frank Le Roy, Dorian Nezam, Diana Pruteanu, Ludivine Lebourg, Steven Grange, Jean-Christophe Plantier, Olivier Boyer, Dominique Guerrot, Sophie Candon
Topics & Concepts
MedicineImmunogenicityCellular immunitySeroconversionImmunologyImmune systemAdjuvantHumoral immunityVaccinationImmunityAsymptomaticKidney transplantAntibodyAntibody responseKidney transplantationClinical trialAcquired immune systemVirologyKidneyVaccine efficacyTransplantationSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy